Cell type dependent endocytic internalization of ErbB2 with an artificial peptide ligand that binds to ErbB2

Toshihiro Hashizume, Takayuki Fukuda, Tadahiro Nagaoka, Hiroko Tada, Hidenori Yamada, Kazuhide Watanabe, David S. Salomon, Masaharu Seno

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

ErbB2, which is a member of the epidermal growth factor (erbB) receptor family, is frequently overexpressed in breast and ovarian cancers. Antibody and small molecule anti-tyrosine kinase inhibitors have been developed for targeted therapies for cancers overexpressing erbB2. Internalization and downregulation of erbB2, which is induced by a ligand, may be important for efficacious therapeutic effects. However, ligand-dependent erbB2 internalization has not been well characterized. Here we investigated the internalization of erbB2 in SKBr3 and SKOv3 cells, both overexpressing erbB2, using an EC-1 peptide fused to eGFP (EC-eGFP), which specifically binds to erbB2. ErbB2 was internalized in SKOv3 cells when the cells were treated with EC-eGFP. The accumulation of endosomal erbB2 was EC-eGFP dependent, which colocalized with transferrin implying endocytosis via clathrin-coated pits. In contrast, internalization of erbB2 was not observed in SKBr3 cells. As a result, two different mechanisms, which are cell type dependent for the internalization of erbB2, are proposed.

Original languageEnglish
Pages (from-to)814-826
Number of pages13
JournalCell Biology International
Volume32
Issue number7
DOIs
Publication statusPublished - 01-07-2008
Externally publishedYes

Fingerprint

Ligands
Peptides
Clathrin
Therapeutic Uses
Transferrin
Endocytosis
Epidermal Growth Factor Receptor
Ovarian Neoplasms
Protein-Tyrosine Kinases
Down-Regulation
Breast Neoplasms
Antibodies
Neoplasms
Therapeutics

All Science Journal Classification (ASJC) codes

  • Cell Biology

Cite this

Hashizume, Toshihiro ; Fukuda, Takayuki ; Nagaoka, Tadahiro ; Tada, Hiroko ; Yamada, Hidenori ; Watanabe, Kazuhide ; Salomon, David S. ; Seno, Masaharu. / Cell type dependent endocytic internalization of ErbB2 with an artificial peptide ligand that binds to ErbB2. In: Cell Biology International. 2008 ; Vol. 32, No. 7. pp. 814-826.
@article{38f8b04eed694f71929c1de60e6a2db4,
title = "Cell type dependent endocytic internalization of ErbB2 with an artificial peptide ligand that binds to ErbB2",
abstract = "ErbB2, which is a member of the epidermal growth factor (erbB) receptor family, is frequently overexpressed in breast and ovarian cancers. Antibody and small molecule anti-tyrosine kinase inhibitors have been developed for targeted therapies for cancers overexpressing erbB2. Internalization and downregulation of erbB2, which is induced by a ligand, may be important for efficacious therapeutic effects. However, ligand-dependent erbB2 internalization has not been well characterized. Here we investigated the internalization of erbB2 in SKBr3 and SKOv3 cells, both overexpressing erbB2, using an EC-1 peptide fused to eGFP (EC-eGFP), which specifically binds to erbB2. ErbB2 was internalized in SKOv3 cells when the cells were treated with EC-eGFP. The accumulation of endosomal erbB2 was EC-eGFP dependent, which colocalized with transferrin implying endocytosis via clathrin-coated pits. In contrast, internalization of erbB2 was not observed in SKBr3 cells. As a result, two different mechanisms, which are cell type dependent for the internalization of erbB2, are proposed.",
author = "Toshihiro Hashizume and Takayuki Fukuda and Tadahiro Nagaoka and Hiroko Tada and Hidenori Yamada and Kazuhide Watanabe and Salomon, {David S.} and Masaharu Seno",
year = "2008",
month = "7",
day = "1",
doi = "10.1016/j.cellbi.2008.03.012",
language = "English",
volume = "32",
pages = "814--826",
journal = "Cell Biology International",
issn = "1065-6995",
publisher = "Portland Press Ltd.",
number = "7",

}

Cell type dependent endocytic internalization of ErbB2 with an artificial peptide ligand that binds to ErbB2. / Hashizume, Toshihiro; Fukuda, Takayuki; Nagaoka, Tadahiro; Tada, Hiroko; Yamada, Hidenori; Watanabe, Kazuhide; Salomon, David S.; Seno, Masaharu.

In: Cell Biology International, Vol. 32, No. 7, 01.07.2008, p. 814-826.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Cell type dependent endocytic internalization of ErbB2 with an artificial peptide ligand that binds to ErbB2

AU - Hashizume, Toshihiro

AU - Fukuda, Takayuki

AU - Nagaoka, Tadahiro

AU - Tada, Hiroko

AU - Yamada, Hidenori

AU - Watanabe, Kazuhide

AU - Salomon, David S.

AU - Seno, Masaharu

PY - 2008/7/1

Y1 - 2008/7/1

N2 - ErbB2, which is a member of the epidermal growth factor (erbB) receptor family, is frequently overexpressed in breast and ovarian cancers. Antibody and small molecule anti-tyrosine kinase inhibitors have been developed for targeted therapies for cancers overexpressing erbB2. Internalization and downregulation of erbB2, which is induced by a ligand, may be important for efficacious therapeutic effects. However, ligand-dependent erbB2 internalization has not been well characterized. Here we investigated the internalization of erbB2 in SKBr3 and SKOv3 cells, both overexpressing erbB2, using an EC-1 peptide fused to eGFP (EC-eGFP), which specifically binds to erbB2. ErbB2 was internalized in SKOv3 cells when the cells were treated with EC-eGFP. The accumulation of endosomal erbB2 was EC-eGFP dependent, which colocalized with transferrin implying endocytosis via clathrin-coated pits. In contrast, internalization of erbB2 was not observed in SKBr3 cells. As a result, two different mechanisms, which are cell type dependent for the internalization of erbB2, are proposed.

AB - ErbB2, which is a member of the epidermal growth factor (erbB) receptor family, is frequently overexpressed in breast and ovarian cancers. Antibody and small molecule anti-tyrosine kinase inhibitors have been developed for targeted therapies for cancers overexpressing erbB2. Internalization and downregulation of erbB2, which is induced by a ligand, may be important for efficacious therapeutic effects. However, ligand-dependent erbB2 internalization has not been well characterized. Here we investigated the internalization of erbB2 in SKBr3 and SKOv3 cells, both overexpressing erbB2, using an EC-1 peptide fused to eGFP (EC-eGFP), which specifically binds to erbB2. ErbB2 was internalized in SKOv3 cells when the cells were treated with EC-eGFP. The accumulation of endosomal erbB2 was EC-eGFP dependent, which colocalized with transferrin implying endocytosis via clathrin-coated pits. In contrast, internalization of erbB2 was not observed in SKBr3 cells. As a result, two different mechanisms, which are cell type dependent for the internalization of erbB2, are proposed.

UR - http://www.scopus.com/inward/record.url?scp=44549087930&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=44549087930&partnerID=8YFLogxK

U2 - 10.1016/j.cellbi.2008.03.012

DO - 10.1016/j.cellbi.2008.03.012

M3 - Article

VL - 32

SP - 814

EP - 826

JO - Cell Biology International

JF - Cell Biology International

SN - 1065-6995

IS - 7

ER -